Jefferies initiates coverage on Haemonetics (NYSE: HAE) with a Buy. PT $48.00.

"Haemonetics is the only pure-play blood management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE